8:00 - 19:00

Working hours MON. - FRI.

 

News

Wall Street Opens Mixed as Cold Snap Hits Retail Sales; Dow Down 40 Pts By Investing.com

By Geoffrey Smith  Investing.com -- U.S. stock markets opened mixed on Tuesday, as a weaker-than-expected retail sales report for February cooled the enthusiasm toward beaten-down cyclical stocks, leaving the tech sector to outperform. By 9:35 AM ET (1435 GMT), the Dow Jones Industrial Average was down 42 points or 0.1%, while the S&P 500 was up 0.1% and the Nasdaq Composite was up 0.7%....

Continue reading

FuelCell Shares Plunge on Lower Revenue, Wider Loss By Investing.com

By Dhirendra Tripathi Investing.com – FuelCell Energy (NASDAQ:FCEL) shares fell 10% Tuesday as lower revenue and a bigger loss than last year prompted traders to dump the stock. For the quarter ended January 31, revenue of $14.87 million fell short of the $16.26 million reported in the same quarter a year ago. The loss from operations more than quadrupled,...

Continue reading

Apple Snares Another Street-High Price Target on Sales Outlook By Investing.com

By Christiana Sciaudone Investing.com -- Apple’s Street-high price target got a second nod from Evercore, which said sales and returns are expected to keep on keeping on. Evercore raised its price target to $175 from $163, matching Wedbush’s target set in late January. Evercore set a bull case price target of $225 and a bear case of $90, saying the “next set of...

Continue reading

UK plans new counter-terrorism centre, says chemical or nuclear attack likely By Reuters

By Michael Holden LONDON (Reuters) - Britain said on Tuesday it would create a new homeland security headquarters as part of plans to improve its response to the "major threat" from terrorism, saying a successful chemical, biological or nuclear was likely by the end of the decade. In its Integrated Review, which lays out the country's post-Brexit policy priorities, the government said...

Continue reading

Moderna Up 2.3% As Firm Begins Trial of Covid-19 Vaccine In Kids  By Investing.com

By Dhirendra Tripathi Investing.com – Moderna (NASDAQ:MRNA) shares were up 2.3% in premarket trade Tuesday after the company said it had begun dosing of its Covid-19 vaccine in children aged between six months and 12 years. The study will assess the safety and effectiveness of two doses of the vaccine, mRNA-1273. It aims to enroll about 6,750 children in...

Continue reading

AstraZeneca, Moderna Rise Premarket; Nikola Falls By Investing.com

By Peter Nurse  Investing.com -- Stocks in focus in premarket trade on Tuesday, March 16th. Please refresh for updates. AstraZeneca (NASDAQ:AZN) ADR rose 2.8% after Canada gave its approval for the drug maker’s Covid-19 vaccine to be used on its population aged 65 and over. Australia also said overnight it will proceed as planned with distributing the vaccine. This comes despite...

Continue reading

Health experts pore over AstraZeneca safety data as Europe reels from vaccine suspensions By Reuters

By Matthias Blamont, Giulia Segreti and Caroline Copley PARIS (Reuters) - Global health experts were under increasing pressure to clear up questions over the safety of AstraZeneca (NASDAQ:AZN)'s COVID-19 shot on Tuesday, as Sweden and Latvia joined countries suspending their use in a further blow to Europe's vaccination rollout. A World Health Organization (WHO) committee of experts was reviewing isolated cases of...

Continue reading

ECB to Ensure Yields Remain in Step With Economy, Lane Tells FT By Bloomberg

(Bloomberg) -- The European Central Bank won’t allow interest rates to rise too soon while the economy still grapples with the coronavirus pandemic, according to its chief economist. “Our objective is basically to make sure the yield curves, which play an important role in determining overall financing conditions, do not move ahead of the economy,” Philip Lane said in an interview with the...

Continue reading

U.S. Retail Sales, Fed Meeting, Europe Vaccine Disarray – What’s up in Markets By Investing.com

By Geoffrey Smith Investing.com --Retail sales data for February will set the tone for the Federal Reserve’s two-day policy meeting that starts later. Industrial production and housing market data are also due. President Xi Jinping tells China’s top economic committee to crack down on regulatory loopholes favoring the country’s tech giants, while Europe’s inoculation campaign is in disarray over a politicized suspension of...

Continue reading
en_GBEnglish